Evidence map›Paper›PMID 38028390›Full record

ArticleMediterranean journal of hematology and infectious diseases2023

Impact of Sars-CoV-2 Prophylaxis with Tixagevimab-Cilgavimab in High-Risk Patients with B-Cell Malignancies: A Single-Center Retrospective Study.

Giovanni Manfredi Assanto, Matteo Totaro, Rebecca Poggiali, Adele Delli Paoli, Giorgia Annechini, Gianna Maria D'Elia, Francesco Aji, Luigi Petrucci, Francesca Fazio, Ilaria Del Giudice and 3 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Giovanni Manfredi AssantoHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Matteo TotaroHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Rebecca PoggialiHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Adele Delli PaoliHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Giorgia AnnechiniHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Gianna Maria D'EliaHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Francesco AjiHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Luigi PetrucciHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Francesca FazioHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Ilaria Del GiudiceHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Maurizio MartelliHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Alessandra MicozziHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Giuseppe GentileHematology, Department of Translational and Precision Medicine, Sapienza University, Rome, Italy.
Sapienza University of Rome · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

B-Cell malignanciesCOVID-19Pre-exposureProphylaxisTixagevimab-cilgavimab

Identifiers

PMID38028390
PMCPMC10631717
OpenAlexW4388108077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.